Showing results (91-100 of 643) with videos related to

Sort By:
Pageof 65
Journal of Neurotrauma|November 19, 2017
Delayed Hypoxemia after Traumatic Brain Injury Exacerbates Long-Term Behavioral DeficitsMcKenzie Davies, Addison Jacobs, David L Brody, et al.
Handbook of Clinical Neurology|February 23, 2015
Current and future diagnostic tools for traumatic brain injury: CT, conventional MRI, and diffusion tensor imagingDavid L Brody, Christine L Mac Donald, Joshua S Shimony
Neuroreport|June 7, 2011
Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatumMiranda M Lim, Jinbin Xu, David M Holtzman, et al.
Neurology|February 28, 2007
Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarkerRandall J Bateman, Guolin Wen, John C Morris, et al.
Neuron|April 21, 2017
Elucidating the Role of TREM2 in Alzheimer's DiseaseJason D Ulrich, Tyler K Ulland, Marco Colonna, et al.
The Journal of Experimental Medicine|October 11, 2022
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreadingNimansha Jain, Caroline A Lewis, Jason D Ulrich, et al.
Plos One|July 7, 2018
Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controlsThomas J Esparza, Mihika Gangolli, Nigel J Cairns, et al.
Plos One|October 8, 2011
Distinct temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic miceHien T Tran, Laura Sanchez, Thomas J Esparza, et al.
Neurocritical Care|September 15, 2005
Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhageDavid L Brody, Venkatesh Aiyagari, Angela M Shackleford, et al.
Plos One|November 8, 2021
Unbiased high-content screening reveals Aβ- and tau-independent synaptotoxic activities in human brain homogenates from Alzheimer's patients and high-pathology controlsHao Jiang, Thomas J Esparza, Terrance T Kummer, et al.
Pageof 65